Approval Recommendations Set Path For Pfizer’s Xeljanz, Japan Tobacco’s HIV Therapy In Japan
This article was originally published in PharmAsia News
Executive Summary
JT’s HIV compound comes home after being joined with Gilead combination therapy. Also approved is Nobelpharma’s glowing red in vivo diagnostic for malignant glioma.